FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,063 letters match. Newest first.

  1. Eco Food Distribution, LLC

    Eco Food Distribution lacked required Foreign Supplier Verification Program records for imported chocolate-covered gingerbread apple and carrot nectar.

    Medium
  2. Sol-ti Inc.

    FDA found Sol-ti's ready-to-drink juices lacked validated pathogen controls and required safety monitoring.

    High risk
  3. AstraZeneca Pharmaceuticals LP

    FDA says AstraZeneca's Breztri sales aid made false or misleading efficacy claims, making the COPD drug misbranded.

    Low
  4. Denison Pharmaceuticals, LLC

    Denison Pharmaceuticals was cited for manufacturing quality failures, contamination risks, and unapproved infant/homeopathic drugs.

    High risk
  5. GTP International Corp

    GTP International, a Mesquite, TX maker of OTC hand sanitizer, refused FDA's repeated requests for manufacturing records.

    Medium
  6. Fancystage Unipessoal, LDA

    Portugal OTC drug maker Fancystage Unipessoal skipped identity testing of high-risk ingredients and lacked quality-unit control, FDA says.

    High risk
  7. Avaria Health & Beauty Corp.

    FDA cites Avaria Health & Beauty for manufacturing-rule violations in OTC drugs, including missing glycerin identity testing and weak quality unit.

    High risk
  8. Tan Alize Kozmetik Ve Temizlik Urunleri

    FDA warns Turkish OTC drug maker Tan Alize over missing glycerin identity testing and a weak quality unit; import alert issued.

    High risk
  9. Sangleaf Pharm., Co. Ltd.

    Sangleaf Pharm failed to give FDA requested records for OTC drugs, including children's toothpaste, at risk of DEG/EG contamination.

    High risk
  10. LCC Ltd.

    LCC Ltd., an OTC drug maker, lacked identity testing for risky ingredients and adequate quality oversight, FDA says.

    High risk
  11. Suhan Aerosol

    Suhan Aerosol, an Indian OTC drug maker, failed to test high-risk ingredients for toxic diethylene/ethylene glycol and lacked quality oversight.

    High risk
  12. Skyline Herbals Private Limited

    FDA warns India's Skyline Herbals after it ignored records requests for OTC drugs including toothpaste; all its drugs hit Import Alert 66-79.

    High risk
  13. Daxal Cosmetics Private Limited

    FDA warns Daxal Cosmetics for refusing records on over-the-counter drugs, including toothpaste, at risk for diethylene glycol and ethylene glycol contamination.

    High risk
  14. US Specialty Formulations, LLC

    US Specialty Formulations, a drug compounder registered as an outsourcing facility, made sterile compounded drugs under insanitary conditions.

    High risk
  15. Centaur Pharmaceuticals Private Ltd.

    FDA says Centaur Pharmaceuticals drugs were adulterated due to inadequate cleaning and cross-contamination.

    High risk
  16. Iso-Tex Diagnostics, Inc.

    FDA warns Iso-Tex Diagnostics over manufacturing violations that risk contamination of sterile radiopharmaceutical drugs.

    High risk
  17. Avlon Industries, Inc.

    FDA warned Avlon Industries that its over-the-counter drug manufacturing broke quality rules, citing missing identity tests for high-risk glycerin/propylene glycol and validation failures.

    High risk
  18. Premier Food Supplies LLC

    FDA says Premier Food Supplies lacked an FSVP for imported snack and pickle products.

    Medium
  19. Jamol Laboratories, Inc.

    FDA found Jamol Laboratories making a nasal emollient under insanitary conditions and without adequate quality control, lab testing, or process validation.

    High risk
  20. Porfirios Italian Foods, Inc.

    FDA says Porfirios Italian Foods made pasta under insanitary conditions without a required food safety plan.

    High risk
  21. BC Food LA, LLC, DBA B & C Food Co.

    BC Food LA lacks U.S. foreign supplier verification for imported cookies, duck eggs, gourd, noodles and other foods.

    Medium
  22. Biosensors Interventional Technologies Pte Ltd

    FDA: Biosensors Singapore stent maker skipped required injury and malfunction reports

    High risk
  23. Five Leaf Pet Botanicals, Inc.

    Five Leaf Pet Botanicals marketed unapproved animal drugs for dogs with disease-treatment claims on its websites.

    Medium
  24. Cheshni Foods LLC

    Cheshni Foods LLC lacked required foreign supplier verification for imported fig jam, cookies, and tahini, FDA says.

    Medium
  25. Bella Mia Foods, Inc.

    FDA warns Bella Mia Foods it lacks required imported-food safety checks for chili powder, cheese, and pastries.

    Medium
  26. Wisetrade Corporation

    Wisetrade Corporation lacked foreign supplier verification records for imported Korean enoki, oyster, and shiitake mushrooms after a Listeria recall.

    High risk
  27. Fuller Industries Inc.

    FDA warns Fuller Industries over current good manufacturing practice violations in OTC hand soaps and sanitizers, including quality oversight and ingredient testing.

    High risk
  28. Eden’s Answers, Inc.

    Eden’s Answers dietary supplements are adulterated by manufacturing-rule violations and misbranded by label omissions.

    Medium
  29. Ocalsa Transport & Logistics, LLC

    Ocalsa Transport & Logistics lacked an FSVP for imported fresh produce and was not FDA-registered.

    Medium
  30. Centaur Pharmaceuticals Private Ltd.

    FDA warns Centaur Pharmaceuticals over manufacturing practice failures in active ingredients, including records and cleaning.

    High risk
  31. C K Frozen Fish and Food Inc.

    FDA found C K Frozen Fish and Food Inc. lacked FSVP records for imported bean seeds and Puja nut.

    Medium
  32. NAFTA Distributors Inc.

    NAFTA Distributors, an Ontario, California food importer, had no Foreign Supplier Verification Program for candies, oils and other foods it imports.

    Medium
  33. NeilMed Pharmaceuticals Inc.

    FDA warned NeilMed Pharmaceuticals that its OTC drug manufacturing had current good manufacturing practice violations, including missing glycerin identity testing and dirty equipment.

    High risk
  34. Bee Healthy Farms LLC

    FDA warned Bee Healthy Farms that website claims made its propolis, royal jelly, honey, and gum products unapproved and misbranded drugs.

    Low
  35. Fruits Tress, Inc.

    FDA warns Fruits Tress, Inc. that it lacked an FSVP for imported fresh watermelon and papaya.

    Medium
  36. Maos Produce

    Maos Produce lacked a required foreign supplier verification program for imported tomatoes, limes, and jalapeno peppers.

    Medium
  37. Schwebel Baking Company

    FDA warned Schwebel Baking that its Hebron, Ohio ready-to-eat bun plant had sesame allergen cross-contact and pest problems.

    High risk
  38. Lacteos Mi Chalatenango, Inc.

    Lacteos Mi Chalatenango, a Saint Paul importer, lacked written assurances from foreign suppliers for candies, sauce and cheese, a repeat violation.

    High risk
  39. Pharmacy Plus, Inc., dba Vital Care Compounder

    FDA warned Pharmacy Plus (Vital Care Compounder) that its sterile compounded drugs were made under insanitary conditions, risking contamination.

    High risk
  40. A&Z Pharmaceutical, Inc.

    A&Z Pharmaceutical marketed a kids’ calcium supplement with disease claims, making it an unapproved and illegally labeled drug.

    Low
  41. RemedyRepack, Inc.

    RemedyRepack, a drug repackager in Indiana, Pennsylvania, failed CGMP, including cleaning and beta-lactam cross-contamination controls.

    High risk
  42. Manzanola Feeds, LLC

    Manzanola Feeds' alfalfa horse cubes contained Clostridium botulinum toxin type C and animal hair, causing an outbreak and recall.

    High risk
  43. Yichang Jiayuan Foodstuffs Co., Ltd

    FDA says Yichang Jiayuan Foodstuffs packed ready-to-eat mandarin oranges under insanitary conditions because glass controls failed.

    High risk
  44. New England Life Care, Inc. dba Advanced Compounding Solutions

    FDA cites Advanced Compounding Solutions for insanitary sterile-drug production and CGMP failures after a 2022 inspection.

    High risk
  45. Champaklal Maganlal Homeo Pharmacy Private Limited

    FDA says Champaklal Maganlal Homeo Pharmacy's Bebelyn diarrhea and colic products are unapproved new drugs for infants.

    High risk
  46. Sure-Biochem Laboratories, LLC

    FDA says contract lab Sure-Biochem missed Burkholderia cepacia in drug samples and cites broad CGMP failures.

    High risk
  47. Pharmedica USA, LLC

    FDA found Pharmedica made ophthalmic and nasal drugs under insanitary conditions without required sterile controls.

    High risk
  48. EarthLab, Inc., dba Wise Woman Herbals

    FDA warned EarthLab, doing business as Wise Woman Herbals, over unapproved drug claims and supplement CGMP violations.

    High risk
  49. Premier Nutra Pharma Inc.

    FDA cited Premier Nutra Pharma, a Carlsbad, California contract maker of nasal spray drugs, for CGMP violations after microbial contamination.

    High risk
  50. Milky Way International Trading Corporation

    FDA found Milky Way International Trading lacked required FSVP records for imported foods, syrups, and coconut cream.

    Medium